The beneficial effects of C-Peptide on diabetic polyneuropathy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The review of diabetic studies : RDS

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1900/RDS.2009.6.187PMID 20039008PMCID PMC2827271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic Neuropathy

  2010cited by this paper
• Dynamic Changes of Neuroskeletal Proteins in DRGs Underlie Impaired Axonal Maturation and Progressive Axonal Degeneration in Type 1 Diabetes

  2009cited by this paper
• C-Peptide and its intracellular signaling.

  2009cited by this paper
• Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy

  2009cited by this paper
• Impaired macrophage recruitment in axotomized diabetic nerve

  2009cited by this paper
• Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.

  2009cited by this paper
• C-peptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes

  2009cited by this paper
• C-Peptide: the missing link in diabetic nephropathy?

  2009cited by this paper
• Inflammation in Diabetic Encephalopathy is Prevented by C-Peptide.

  2009cited by this paper
• Zinc-activated C-peptide resistance to the type 2 diabetic erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin.

  2009cited by this paper
• A Molecular Level Understanding of Zinc Activation of C-peptide and its Effects on Cellular Communication in the Bloodstream.

  2009cited by this paper
• Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide.

  2009cited by this paper
• Anti-inflammatory properties of C-Peptide.

  2009cited by this paper
• Molecular effects of C-Peptide in microvascular blood flow regulation.

  2009cited by this paper
• Role of C-Peptide in the Regulation of Microvascular Blood Flow

  2008cited by this paper
• Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study.

  2008cited by this paper
• Intracellular Signalling by C-Peptide

  2008cited by this paper
• Incidence of type 1 diabetes mellitus and associated complications among children and young adults: results from Karnataka Diabetes Registry 1995-2008.

  2008cited by this paper
• Children developing type 1 diabetes before 6 years of age have increased linear growth independent of HLA genotypes

  2008cited by this paper
• Diabetic Neuropathy: Clinical Management

  2008cited by this paper
• Cognition and diabetes: a lifespan perspective.

  2008cited by this paper
• The heterogeneity of diabetic neuropathy.

  2008cited by this paper
• Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-κB pathway

  2008influential reference
• Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy.

  2008influential reference
• Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?

  2008cited by this paper
• Alzheimer-Like Changes in Rat Models of Spontaneous Diabetes

  2007cited by this paper
• Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter

  2007cited by this paper
• Insulin potentiates Ca2+ signaling and phosphatidylinositol 4,5-bisphosphate hydrolysis induced by Gq protein-coupled receptor agonists through an mTOR-dependent pathway.

  2007cited by this paper
• Pathogenesis of Spinally Mediated Hyperalgesia in Diabetes

  2007cited by this paper
• Pathogenesis of Spinally Mediated Hyperalgesia in

  2007cited by this paper
• Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats

  2006cited by this paper
• Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects

  2006influential reference
• Diabetic Neuropathy Differs in Type 1 and Type 2 Diabetes

  2006cited by this paper
• C-Peptide Reverses Nociceptive Neuropathy in Type 1 Diabetes

  2006cited by this paper
• Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials.

  2005cited by this paper
• The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats.

  2005cited by this paper
• Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes

  2005cited by this paper
• Apoptotic stress is counterbalanced by survival elements preventing programmed cell death of dorsal root ganglions in subacute type 1 diabetic BB/Wor rats.

  2005cited by this paper
• Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes.

  2004cited by this paper
• Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide.

  2004cited by this paper
• C-peptide, Na+,K+-ATPase, and Diabetes

  2004cited by this paper
• Direct insulin signaling of neurons reverses diabetic neuropathy.

  2004cited by this paper
• The C-peptide Signaling

  2004cited by this paper
• Experimental Rat Models of Types 1 and 2 Diabetes Differ in Sympathetic Neuroaxonal Dystrophy

  2004cited by this paper
• Pathophysiology of neuropathic pain.

  2004cited by this paper
• C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats.

  2004cited by this paper
• Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide.

  2004cited by this paper
• C‐peptide prevents nociceptive sensory neuropathy in type 1 diabetes

  2004cited by this paper
• Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition.

  2003cited by this paper
• Proinsulin C‐Peptide Replacement in Type 1 Diabetic BB/Wor‐rats Prevents Deficits in Nerve Fiber Regeneration

  2003cited by this paper
• Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy.

  2003cited by this paper
• Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats

  2003cited by this paper
• Insulin Deficiency Rather than Hyperglycemia Accounts for Impaired Neurotrophic Responses and Nerve Fiber Regeneration in Type 1 Diabetic Neuropathy

  2003cited by this paper
• C‐peptide enhances insulin‐mediated cell growth and protection against high glucose–induced apoptosis in SH‐SY5Y cells

  2003cited by this paper
• New insights into the metabolic and molecular basis for diabetic neuropathy

  2003cited by this paper
• Neuropathic pain and diabetes

  2003cited by this paper
• Receptor protein tyrosine phosphatases in nervous system development.

  2003cited by this paper
• Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes.

  2003cited by this paper
• Sensory neurons with activated caspase-3 survive long-term experimental diabetes.

  2003cited by this paper
• Altered Tubulin and Neurofilament Expression and Impaired Axonal Growth in Diabetic Nerve Regeneration

  2002cited by this paper
• Early Gene Responses of Trophic Factors in Nerve Regeneration Differ in Experimental Type 1 and Type 2 Diabetic Polyneuropathies

  2002cited by this paper
• Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord

  2002cited by this paper
• A role for mitogen‐activated protein kinases in the etiology of diabetic neuropathy

  2001influential reference
• C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts.

  2001cited by this paper
• Cognitive effects of insulin in the central nervous system.

  2001cited by this paper
• Molecular basis for the insulinomimetic effects of C-peptide

  2001cited by this paper
• Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy.

  2001cited by this paper
• C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat

  2001cited by this paper
• Altered Immediate Early Gene Expression in Injured Diabetic Nerve: Implications in Regeneration

  2001cited by this paper
• A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase β

  2000influential reference
• Beneficial effects of C‐peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

  2000cited by this paper
• Facilitation of the withdrawal reflex by repeated transcutaneous electrical stimulation: an experimental study on central integration in humans

  2000cited by this paper
• Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3.

  2000influential reference
• A comparison of diabetic polyneuropathy in Type II diabetic BBZDR/Wor rats and in Type I diabetic BB/Wor rats

  2000cited by this paper
• Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms

  2000cited by this paper
• C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin.

  1999cited by this paper
• Neurons undergo apoptosis in animal and cell culture models of diabetes.

  1999cited by this paper
• Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

  1999cited by this paper
• Tetrodotoxin-resistant sodium channels of dorsal root ganglion neurons are readily activated in diabetic rats.

  1999cited by this paper
• Specific binding of proinsulin C-peptide to human cell membranes.

  1999cited by this paper
• Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Delayed Wallerian degeneration and increased neurofilament phosphorylation in sciatic nerves of rats with streptozocin-induced diabetes.

  1998cited by this paper
• Proinsulin C-Peptide-Biological Activity?

  1997cited by this paper
• Identification of a novel contactin‐associated transmembrane receptor with multiple domains implicated in protein–protein interactions

  1997influential reference
• Neuropathology of diabetic neuropathy and its correlations with neurophysiology.

  1997cited by this paper
• Peripheral nerve regeneration.

  1996cited by this paper
• Complications in IDDM are caused by elevated blood glucose level: The Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up

  1996cited by this paper
• Glucose transporters in rat peripheral nerve: paranodal expression of GLUT1 and GLUT3.

  1996cited by this paper
• C-peptide improves autonomic nerve function in IDDM patients

  1996cited by this paper
• C-peptide stimulates rat renal tubular Na+, K+-ATPase activity in synergism with neuropeptide Y

  1996cited by this paper
• Nodal Na(+)-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition.

  1996cited by this paper
• Nerve fiber regeneration following axotomy in the diabetic biobreeding Worcester rat: the effect of ARI treatment.

  1996cited by this paper
• Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy.

  1995cited by this paper
• Insulin action and the insulin signaling network.

  1995cited by this paper
• The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin.

  1995cited by this paper
• AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier.

  1995cited by this paper
• The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

  1994cited by this paper
• Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper

• Postprandial C-Peptide to Glucose Ratio as a Promising Systemic Marker of Diabetic Retinopathy in Type 2 Diabetes

  2025cites this paper
• Construction and validation of a nomogram model for predicting diabetic peripheral neuropathy

  2024cites this paper
• Peripheral nerve conduction speed shows a disease control-dependent and -independent drop in type 1 diabetes mellitus in children

  2022cites this paper
• Generation of a Beta-Cell Transplant Animal Model of Diabetes Using CRISPR Technology.

  2022cites this paper
• Plant‐based diets and diabetic neuropathy: A systematic review

  2020cites this paper
• Lentivirus mediated pancreatic beta-cell specific insulin gene therapy for STZ-induced Diabetes.

  2020cites this paper
• L-carnitine ameliorates peripheral neuropathy in diabetic mice with a corresponding increase in insulin‑like growth factor‑1 level.

  2018cites this paper
• C-peptide is independent associated with diabetic peripheral neuropathy: a community-based study

  2017cites this paper
• Effect of intravenous versus subcutaneous insulin delivery on the intensity of neuropathic pain in diabetic subjects.

  2015cites this paper
• Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, is Associated With Peripheral Neuropathy in Patients With Type 2 Diabetes

  2015cites this paper
• C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy.

  2014cites this paper
• Mechanisms of diabetic neuropathy: axon dysfunction.

  2014influential citation
• Clinical utility of insulin and insulin analogs

  2013cites this paper
• Axonal dysfunction prior to neuropathy onset in type 1 diabetes

  2013cites this paper
• The Therapeutic Role of C-peptide in the Amelioration of Type 1 Diabetes Associated Microvascular Dysfunction of the Kidneys and Nerves

  2013cites this paper
• C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up.

  2012cites this paper
• Linking Diabetic Complications to Sorbitol Oxidation, Oxidative Stress and Metabolic Suppression

  2012cites this paper
• Angiotensin-converting enzyme gene single polymorphism as a genetic biomarker of diabetic peripheral neuropathy: longitudinal prospective study.

  2012cites this paper
• Angiotensin Converting Enzyme Gene Polymorphism as a Genetic Biomarker of Diabetic Peripheral Neuropathy: Longitudinal Prospective Study

  2012cites this paper
• C-Peptide and Type 1 Diabetic Encephalopathy

  2012cites this paper
• The Effect of Combined C-Peptide and Zinc on Cellular Function

  2012cites this paper
• Proinsulin C-peptide activates α-enolase: implications for C-peptide--cell membrane interaction.

  2012cites this paper
• Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients

  2012cites this paper
• Antioxidant and Radical Scavenging Properties of Garlic Oil in Streptozotocin Induced Diabetic Rats

  2011cites this paper
• The Presynaptic F-box Protein FSN-1 Regulates Synapse Development via Retrograde Insulin Signaling in Caenorhabditis elegans

  2010cites this paper
• Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide.

  2009cites this paper